Adverse events of raltegravir and dolutegravir

OBJECTIVE: To compare the frequency and risk factors of toxicity-related treatment discontinuations between raltegravir and dolutegravir. DESIGN: Prospective cohort study. METHODS: All antiretroviral therapy (ART)-naïve and ART-experienced HIV-infected individuals from the Swiss HIV Cohort Study who...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:AIDS
Main Authors: Elzi, Luigia, Erb, Stefan, Furrer, Hansjakob, Cavassini, Matthias, Calmy, Alexandra, Vernazza, Pietro, Günthard, Huldrych, Bernasconi, Enos, Battegay, Manuel
Formato: Artigo
Idioma:Inglês
Publicado: Lippincott Williams & Wilkins 2017
Assuntos:
Clinical Science: Concise Communications
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5566167/
https://ncbi.nlm.nih.gov/pubmed/28692533
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAD.0000000000001590
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares